Image showing the outer wrap of the Evolut PRO Transcatheter Aortic Valve

Evolut™ PRO+ TAVI SYSTEM NOW CE MARKED

CONTACT US

OVERVIEW

The Evolut™ PRO system is the next-generation, self-expanding transcatheter aortic valve with exceptional design and advanced sealing capability. The Evolut™ PRO system features a unique valve design with an outer wrap that adds surface area contact between the valve and the native aortic annulus to further advance valve sealing performance. 

EvolutTM PRO+ System Sealing + Performance

From a design built on a proven platform1 , the Evolut™ PRO+ system is taking valve performance and patient outcomes above and beyond.

EVOLUT™ TAVI

NOW CE MARKED

FOR LOW RISK SEVERE AORTIC STENOSIS PATIENTS

Learn more
TAVI Couple Cycling
Animation of Evolut Pro TAVR showing the three leaflets opening and closing into the aorta

OVERVIEW

The Evolut™ PRO system is the next-generation, self-expanding transcatheter aortic valve with exceptional design and advanced sealing capability. The Evolut™ PRO system features a unique valve design with an outer wrap that adds surface area contact between the valve and the native aortic annulus to further advance valve sealing performance.

Superior HEMODYNAMICS

Evolut™ TAVI is the only TAVI device to demonstrate hemodynamic superiority in a low risk clinical trial vs. SAVR at one year.2

EVOLUT™ THE FIRST AND ONLY

TAVI platform CE marked for treatment of patients with severe Bicuspid aortic stenosis*.

Why Evolut
Older Lady in Purple Walking Outdoors with Sticks

 Learn More About Evolut™ PRO

Product Details
man-smiling

LEARN MORE ABOUT EVOLUT™ CLINICAL EVIDENCE

SEE THE DATA

Contact Us to Learn More

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email preferences (e.g. a Medtronic representative may still reply to your specific request by email, per your selection). Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

References

1

Data on file (>20 randomized controlled trials with over 20000 patients enrolled).

2

Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. May 2, 2019;380(18):1706-1715.

*Evolut™ TAVI Platform is indicated for treatment of patients with severe bicuspid aortic stenosis who are at intermediate or greater risk for SAVR.

See the CoreValve Evolut R and CoreValve Evolut PRO device manuals for detailed information regarding the instructions for use , indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.

For applicable products, consult instructions for use at www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.

The commercial name of the Evolut™ R device is Medtronic CoreValve™ Evolut™ R System, and the commercial name of the Evolut™ PRO device is Medtronic Corevalve™ Evolut PRO System 

© 2020 Medtronic. All rights reserved, Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic™.* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.